The largest database of trusted experimental protocols

10 protocols using esi 05

1

Modulation of Malaria Merozoite Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols

P. falciparum merozoites were isolated in IC buffer and treated for 15 mins with the following at concentrations shown: 100 µM IBMX (3-isobutyl-1-methylxanthine, Calbiochem, USA), 50 µM KH7 (Calbiochem, USA), 100 µM ACTZ (acetazolamide, Sigma, USA), 20 µM DiB-cAMP (adenosine 3,5 cyclic monophosphate, N6, O2- dibutyryl sodium salt, Calbiochem, USA), 10 µM Ca2+ ionophore A23187 (Calbiochem, USA), 50 µM BAPTA-AM (Calbiochem, USA), 10 µM U73122 (Calbiochem, USA), 10 µM U73343 (Calbiochem, USA), 200 µM Epac agonist (8-pCPT-2’-O-Me-cAMP, Sigma, USA), 25 µM Epac antagonist ESI-05 (Biolog, Germany), 25 µM Epac antagonist ESI-09 (Biolog, Germany) and 50 µM geranyl geranyl transferase inhibitor, GGTI 298, which disrupts Rap1 function. Merozoites were then transferred to EC buffer (5 mM KCl, 140 mM NaCl, 1 mM MgCl2, 2 mM EGTA, 5.6 mM glucose, 25 mM HEPES, pH 7.2) followed by either measurement of cytosolic cAMP and Ca2+ levels in merozoites or microneme secretion.
+ Open protocol
+ Expand
2

Measuring P. falciparum Merozoite Invasion Rates

Check if the same lab product or an alternative is used in the 5 most similar protocols

P. falciparum merozoites isolated as described above were either mock-treated or treated with 50 µm KH7 (Calbiochem, USA), 100 µm ACTZ (Sigma, USA), 25 µM ESI-05 (Biolog, Germany) or 25 µM ESI-09 (Biolog, Germany) for 15 min at 37°C, washed with IC buffer, resuspended in EC buffer and incubated with erythrocytes in EC buffer at 37°C under mixed gas environment for 2 h to allow invasion. EC buffer was then replaced with complete RPMI. After 18–20 h of incubation in complete RPMI under mixed gas environment to allow development of ring stages, the percentage of infected erythrocytes was scored by flow cytometry to determine invasion rates, as described earlier [52] (link).
+ Open protocol
+ Expand
3

Signaling Pathway Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glucagon and insulin were purchased from Sigma‐Aldrich (St Louis, MO, USA); 8‐CPT‐2‐O‐Me‐cAMP (8‐CPT), 6‐Bnz‐cAMP, and ESI‐05 were purchased from Biolog (Bremen, Germany). GP inhibitor (GPi) was purchased from Calbiochem (San Diego, CA, USA). Anti‐phospho‐CREB (Ser133) and anti‐CREB were purchased from Cell Signaling Technology (Danvers, MA, USA), anti‐Epac2 from Proteintech (Chicago, IL, USA), anti‐Rap1 from Millipore, peroxidase‐conjugated anti‐rabbit IgG and anti‐mouse IgG from Jackson Immuno Research (West Grove, PA, USA), anti‐glucokinase was produced in‐house
19 (link), and Alexa Fluor 488‐conjugated anti‐rabbit IgG (H + L) was purchased from Thermo Fisher Scientific (Waltham, MA, USA).
+ Open protocol
+ Expand
4

Doxorubicin Cardiotoxicity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dox (2 mg/mL) and dexrazoxane were obtained from ACCORD (central pharmacy of Institut Gustave Roussy, Villejuif, France) and Sigma (St Quentin Fallavier, France), respectively. The in vitro Dox exposure of isolated cardiomyocytes was of 1–10 µM in concordance with literature recommendation (Tokarska-Schlattner et al., 2006 (link)) and extended to match tumor cell lines exposure requirements.
8-(4-Chloro-phenylthio)-2’-O-methyladenosine-3’5’cyclic monophosphate (8-CPT), ESI-09, and ESI-05 were from Biolog Life Science Institute (Bremen, Germany). ZVAD-fmk was from Bachem (Bubendorf, Switzerland). EPAC1 specific inhibitor (R)-CE3F4 was provided by Dr Ambroise (CEA, Gif-sur-Yvette, France) (Courilleau et al., 2013 (link)).
+ Open protocol
+ Expand
5

Preparation of MK-4, H89, and ESI-05 Stock Solutions

Check if the same lab product or an alternative is used in the 5 most similar protocols
MK-4 was obtained from Nisshin Pharma Inc. (Tokyo, Japan) and dissolved in ethanol to obtain a stock solution (50 mM); it was then stored in the dark at −20 °C. H89 (Sigma-Aldrich, St. Louis, MO, USA) and ESI-05 (4-methylphenyl-2,4,6-trimethlyphenylsulfone; BIOLOG Life Science Institute, Bremen, Germany), which are inhibitors of PKA and Epac2, respectively, were dissolved in dimethyl sulfoxide (Sigma-Aldrich) to obtain stock solutions (10 mM) at −20 °C.
+ Open protocol
+ Expand
6

Calcium Signaling in Rat Ventricular Myocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wistar rats (150–200 g) were sacrificed in accordance with the UK Home Office Guidance on the Operation of Animals (Scientific Procedures) Act of 1986. ARVMs were isolated by collagenase digestion as described previously (61 (link)). ARVMs were perfused with solutions containing (mM) 113 NaCl; 5.4 KCl; 1 MgCl2; 1.0 CaCl2; 0.37 Na2HPO4; 5.5 glucose; and 5 HEPES, 20–22°C, pH 7.1. Changes in intracellular calcium ([Ca2+]i) were detected by loading myocytes with fluo-4 AM (5 μM) for 15 min at room temperature (20–22°C). A further 30 min was allowed for washout of fluo-4 AM and de-esterification.
Unless otherwise stated, all chemicals were obtained from Sigma Aldrich. The selective Epac2 inhibitors, ESI-05 (35 (link), 50 (link)) and HJC0350 (14 (link)), were obtained from Biolog and Bio-techne/Tocris, respectively. The GGT-1 inhibitor, GGTI-298 (22 (link)), is the ester prodrug form of the parent compound GGTI-297 and both were obtained from Bio-techne/Tocris. In some experiments, GGTI-297 was introduced via a patch pipette during whole-cell patch-clamp recording, while GGTI-298 was added via the bathing solution. The GGT-1 inhibitor, GGTI-2147, was obtained from Calbiochem. Active Rap1 pull-down and detection kits were obtained from ThermoFisher Scientific.
+ Open protocol
+ Expand
7

Modulation of Ca2+ Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following substances were used (source given in parentheses): the L-type Ca2+ channel blocker isradipine and the P/Q Ca2+ channel blocker ω-agatoxin (Alomone Labs; Jerusalem, Israel); the α1-antagonist prazosin (Abcam, Cambridge, UK); the membrane-permeable PKA inhibitor myr-PKI, the IP3 receptor inhibitor Xestospongin C, the NAADP antagonist Ned-19, the V-ATPase inhibitor bafilomycin, the sER ATPase inhibitor thapsigargin and noradrenaline (Tocris Bioscience, Bristol, UK); the EPAC2 inhibitor ESI-05 (BioLog, Bremen, Germany); the insulin receptor antagonist (S961, Novo-Nordisk, Denmark). All other compounds were obtained from Sigma-Aldrich (Dorset, UK).
+ Open protocol
+ Expand
8

Evaluation of Cellular Signaling Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture reagents were obtained from Invitrogen (Darmstadt, Germany). The anti-pERK-1/2 (E-4) and the anti-Rap-1a (sc-1482) antiserum was from Santa Cruz (Heidelberg, Germany). The pCREB-Ser-133 antibody was purchased from cell signaling (Leiden, the Netherlands). The anti-tubulin (clone 6-11B-1) and the peroxidase-conjugated anti-mouse or anti-rabbit antibody, both raised in goat, from Bio-Rad (München, Germany). The firefly luciferase substrate was from Promega (Mannheim, Germany). rp-Br-cAMPs and γ-MSH were from SigmaAldrich (Deisenhofen, Germany). ESI-09, ESI-05 and HJC-0197 were from Biolog (Bremen, Germany), A-812511 from abcam (Cambridge, UK) and PD-184,352, HS-024 or NPY from Tocris (Bristol, UK). α-MSH was from Biotrend (Cologne, Germany) and KT-5720 from Enzo life science (Lörrach, Germany).
+ Open protocol
+ Expand
9

Excitatory Synaptic Transmission Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For mEPSC recordings, TTX (Sigma) was added to the bath solution to only measure excitatory spontaneous release. For investigation of the cAMP-GluA3-dependent pathway, we used FSK (Sigma), H89 (Tocris), KT5720 (Sigma), ESI-05 (BioLog), and 8-CPT-2Me-cAMP (Tocris Bioscience). To obtain a monophasic time decay of the AMPA-evoked responses in outside-out patches, we added PEPA (Tocris bioscience) and cyclothiazide (Tocris bioscience).
+ Open protocol
+ Expand
10

Doxorubicin Cardiotoxicity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dox (2 mg/mL) and dexrazoxane were obtained from ACCORD (central pharmacy of Institut Gustave Roussy, Villejuif, France) and Sigma (St Quentin Fallavier, France), respectively. The in vitro Dox exposure of isolated cardiomyocytes was of 1–10 µM in concordance with literature recommendation (Tokarska-Schlattner et al., 2006 (link)) and extended to match tumor cell lines exposure requirements.
8-(4-Chloro-phenylthio)-2’-O-methyladenosine-3’5’cyclic monophosphate (8-CPT), ESI-09, and ESI-05 were from Biolog Life Science Institute (Bremen, Germany). ZVAD-fmk was from Bachem (Bubendorf, Switzerland). EPAC1 specific inhibitor (R)-CE3F4 was provided by Dr Ambroise (CEA, Gif-sur-Yvette, France) (Courilleau et al., 2013 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!